Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeGiulio Marchesini, Mario Rizzetto|Hepatology|2003Cited by 2.7k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, Rafael Violante Ortíz et al.|The Lancet|2017Cited by 843
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver DiseaseStefania Grimaudo, Salvatore Petta, Rosaria Maria Pipitone et al.|Clinical Gastroenterology and Hepatology|2019Cited by 152